news
Sanofi Pasteur announces support for the Human Vaccines Project
14 January 2016 | By Victoria White
The Human Vaccines Project is a research programme designed to accelerate the development of vaccines by decoding the human immune system...
List view / Grid view
HIV
news
Aelix completes €11.5 M Series A funding for therapeutic HIV vaccine
11 January 2016 | By Victoria White
The proceeds will support the development of Aelix’s lead candidate HTI immunogen as a therapeutic vaccine against HIV infection up to the completion of a Phase 2 proof-of-concept efficacy trial in HIV-infected individuals...
news
Gamma interferon protects mice from Ebola
19 November 2015 | By Victoria White
A new study suggests that gamma interferon, which is an FDA-approved drug, may have potential as an antiviral therapy to prevent Ebola infection when given either before or after exposure to the virus...
news
TSRI scientists use trait of anti-HIV antibodies to develop vaccine candidates
18 November 2015 | By Victoria White
When studying prototype antibodies that target a specific weak spot on HIV, the researchers noted two of the antibodies had an unusual feature that could prove important in vaccine design...
news
Sanofi Pasteur reveals universal flu vaccine research
10 November 2015 | By Victoria White
Sanofi Pasteur's experimental vaccine is a novel synthetic vaccine generated from key genetic sequences of many flu viruses...
news
Leading HIV scientists launch project to develop HIV vaccine
3 November 2015 | By Kate Douetil
The European AIDS Vaccine Initiative (EAVI2020) is a new EUR 23 million project, financed by the European Commission...
news
H7N9 influenza vaccine failure due to “immune camouflage”
28 September 2015 | By Victoria White
H7N9 candidate vaccines have failed to elicit a strong immune response necessary to protect from infection. A study has revealed that it may be due to immune camouflage...
news
TSRI awarded $6 million to develop HIV/AIDS vaccine, eCD4-lg
25 September 2015 | By Victoria White
When eCD4-lg was tested in animal models, the results were so powerful and effective that they suggested the compound’s potential to serve the role of an alternative HIV/AIDS vaccine...
news
ERManI protein prevents HIV virus from replicating
17 September 2015 | By Vicky White
By identifying ERManI as the target that slows the spread of HIV-1, researchers have revealed a target in which future therapies can be developed...
news
USP19 inhibition protects against muscle wasting
15 September 2015 | By Victoria White
Researchers have discovered a new gene, USP19, involved in the muscle wasting syndrome cachexia that could be a good target for drug development...
news
Kymab on Sunday Times Tech Track ‘Ones to Watch’ list
7 September 2015 | By Victoria White
The ranking recognises Kymab’s potential for rapid future sales growth and increasing international presence...
news
CLR01 targets HIV and prevents semen from promoting infection
18 August 2015 | By Victoria White
Researchers have discovered a small molecule, known as CLR01, that attacks the HIV virus and disrupts the amyloids in semen that promote HIV infection...
news
Bionic liver organs explain toxicity of paracetamol
17 August 2015 | By Victoria White
Scientists have created a liver-on-chip device mimicking human physiology, leading to the discovery of a new mechanism of paracetamol toxicity...
news
Researchers uncover the signals that govern the fate of TFH cells
31 July 2015 | By Victoria White
Researchers identify a pair of master regulators that control the fate of follicular helper T (TFH) cells - a finding that could improve vaccine design...
news
Scientists successfully edit human T cells using CRISPR
29 July 2015 | By Victoria White
Scientists have precisely modifed human T cells using the CRISPR genome-editing system- a breakthrough that could lead to CRISPR/Cas9-based therapies...
